Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$280M |
| 3 |
Morgan Stanley
MS
|
+$265M |
| 4 |
American Tower
AMT
|
+$262M |
| 5 |
Charles Schwab
SCHW
|
+$261M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$132M |
Sector Composition
| 1 | Technology | 24.26% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
2626
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.82M | ﹤0.01% |
381,367
+16,050
| +4% | +$203K |
|
2627
Schwab Emerging Markets Equity ETF
SCHE
$11.1B
| – | – |
0
| – | -$4.2M |
|
2628
Greif Class B
GEF.B
$2.46B
| $4.8M | ﹤0.01% |
99,222
+16,825
| +20% | +$814K |
|
2629
Central Garden & Pet
CENT
$2.24B
| $4.78M | ﹤0.01% |
154,816
+14,163
| +10% | +$437K |
|
2630
Methanex
MEOH
$3.04B
| $4.77M | ﹤0.01% |
100,465
+10
| +0% | +$474 |
|
|
IVC
2631
DELISTED
Invacare Corporation
IVC
| $4.74M | ﹤0.01% |
529,351
+15,373
| +3% | +$138K |
|
|
HCCI
2632
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $4.73M | ﹤0.01% |
224,587
+5,672
| +3% | +$120K |
|
|
GATO
2633
DELISTED
Gatos Silver, Inc.
GATO
| $4.73M | ﹤0.01% |
+362,959
| New | +$4.73M |
|
2634
Marcus Corp
MCS
$504M
| $4.72M | ﹤0.01% |
350,314
+18,091
| +5% | +$244K |
|
|
AKUS
2635
DELISTED
Akouos, Inc. Common Stock
AKUS
| $4.71M | ﹤0.01% |
237,275
+12,653
| +6% | +$251K |
|
|
TBCH
2636
Turtle Beach Corporation Common Stock
TBCH
$299M
| $4.7M | ﹤0.01% |
218,019
+9,306
| +4% | +$201K |
|
2637
SoundThinking
SSTI
$160M
| $4.69M | ﹤0.01% |
124,461
+4,079
| +3% | +$154K |
|
2638
Waste Connections
WCN
$45.3B
| $4.68M | ﹤0.01% |
48,538
+3,750
| +8% | +$362K |
|
|
MRNS
2639
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.68M | ﹤0.01% |
383,686
+36,888
| +11% | +$450K |
|
2640
Cross Country Healthcare
CCRN
$411M
| $4.68M | ﹤0.01% |
527,142
-13,739
| -3% | -$122K |
|
|
CALA
2641
DELISTED
Calithera Biosciences, Inc
CALA
| $4.67M | ﹤0.01% |
47,596
+411
| +0.9% | +$40.4K |
|
2642
West Bancorporation
WTBA
$344M
| $4.67M | ﹤0.01% |
242,071
+5,095
| +2% | +$98.3K |
|
|
NOAH
2643
Noah Holdings
NOAH
$781M
| $4.62M | ﹤0.01% |
97,601
+4,499
| +5% | +$213K |
|
2644
Matrix Service
MTRX
$353M
| $4.62M | ﹤0.01% |
419,339
+6,877
| +2% | +$75.8K |
|
|
ATHX
2645
DELISTED
Athersys, Inc. Common Stock
ATHX
| $4.61M | ﹤0.01% |
105,429
+2,294
| +2% | +$100K |
|
|
MTEM
2646
DELISTED
Molecular Templates, Inc.
MTEM
| $4.61M | ﹤0.01% |
32,706
+1,438
| +5% | +$203K |
|
2647
TherapeuticsMD
TXMD
$12.8M
| $4.6M | ﹤0.01% |
76,079
+6,099
| +9% | +$369K |
|
|
QEP
2648
DELISTED
QEP RESOURCES, INC.
QEP
| $4.6M | ﹤0.01% |
1,925,630
+25,128
| +1% | +$60.1K |
|
|
AFIB
2649
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $4.59M | ﹤0.01% |
159,433
+8,055
| +5% | +$232K |
|
2650
Red Robin
RRGB
$121M
| $4.59M | ﹤0.01% |
238,814
+27,988
| +13% | +$538K |
|